Blum Robert I's Form 4 filing
Cytokinetics Inc (CYTK) · filed Aug 10, 2026
- Accession no.
- 0001061983-26-000087
- Filed
- Aug 10, 2026, 5:11 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $575.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blum Robert ICIK 0001288859 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | MOption exerciseAcquired | +7,500 | $10.60 | +$79,500 | 385,320 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −7,500 | $76.76 | −$575,700 | 377,820 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 171,745 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.